Payment overview · 2025
General Payments
1 reported records · 1 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Family Medicine · MIAMI, FL · NPI 1003845926
Verified facts
CMS Open Payments records show Elena Marta Pernas, DO received $18.22 in general payments during 2025 across 1 reported records.
ABBVIE INC. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 87 claims for Synthroid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
1 reported records · 1 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $18.22 | 100.0% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $18.22 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| BOTOX Normalized: botox |
Biological | ABBVIE INC. | $18.22 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
17 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
87 | 16 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Folic Acid | Folic Acid | 1001 | 384 |
| Atorvastatin Calcium | Atorvastatin Calcium | 857 | 282 |
| Gabapentin | Gabapentin | 620 | 157 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 598 | 200 |
| Omeprazole | Omeprazole | 567 | 191 |
| Losartan Potassium | Losartan Potassium | 549 | 162 |
| Lisinopril | Lisinopril | 463 | 120 |
| Amlodipine Besylate | Amlodipine Besylate | 453 | 145 |
| Levothyroxine Sodium | Levothyroxine Sodium | 439 | 133 |
| Famotidine | Famotidine | 397 | 152 |
| Metformin Hcl | Metformin Hcl | 372 | 113 |
| Alprazolam | Alprazolam | 368 | 83 |
| Fluticasone Propionate | Fluticasone Propionate | 348 | 147 |
| Metoprolol Succinate | Metoprolol Succinate | 346 | 112 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 309 | 79 |
| Furosemide | Furosemide | 309 | 118 |
| Simvastatin | Simvastatin | 301 | 92 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 300 | 126 |
| Hydrochlorothiazide | Hydrochlorothiazide | 278 | 91 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 254 | 105 |
| Pantoprazole Sodium | Pantoprazole Sodium | 250 | 96 |
| Celecoxib | Celecoxib | 241 | 81 |
| Mupirocin | Mupirocin | 233 | 105 |
| Sildenafil Citrate | Sildenafil Citrate | 223 | 53 |
| Irbesartan | Irbesartan | 218 | 56 |
| Tizanidine Hcl | Tizanidine Hcl | 214 | 93 |
| Xarelto | Rivaroxaban | 213 | 49 |
| Clopidogrel | Clopidogrel Bisulfate | 205 | 70 |
| Diclofenac Sodium | Diclofenac Sodium | 205 | 87 |
| Lorazepam | Lorazepam | 197 | 27 |
| Alendronate Sodium | Alendronate Sodium | 196 | 78 |
| Glipizide | Glipizide | 196 | 48 |
| Tamsulosin Hcl | Tamsulosin Hcl | 192 | 65 |
| Temazepam | Temazepam | 190 | 43 |
| Donepezil Hcl | Donepezil Hcl | 187 | 61 |
| Ibuprofen | Ibuprofen | 173 | 82 |
| Benzonatate | Benzonatate | 170 | 89 |
| Tramadol Hcl | Tramadol Hcl | 170 | 60 |
| Glipizide Er | Glipizide | 169 | 47 |
| Eliquis | Apixaban | 168 | 34 |
| Metoprolol Tartrate | Metoprolol Tartrate | 168 | 49 |
| Buspirone Hcl | Buspirone Hcl | 165 | 66 |
| Fenofibrate | Fenofibrate | 155 | 49 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 155 | 48 |
| Azithromycin | Azithromycin | 152 | 109 |
| Quetiapine Fumarate | Quetiapine Fumarate | 151 | 42 |
| Trazodone Hcl | Trazodone Hcl | 151 | 54 |
| Clonazepam | Clonazepam | 148 | 31 |
| Mirtazapine | Mirtazapine | 140 | 57 |
| Lactulose | Lactulose | 134 | 63 |
| Meloxicam | Meloxicam | 134 | 57 |
| Carvedilol | Carvedilol | 133 | 36 |
| Hydrocortisone | Hydrocortisone | 124 | 55 |
| Warfarin Sodium | Warfarin Sodium | 121 | suppressed |
| Ketoconazole | Ketoconazole | 114 | 36 |
| Montelukast Sodium | Montelukast Sodium | 114 | 34 |
| Alogliptin | Alogliptin Benzoate | 111 | 24 |
| Nifedipine Er | Nifedipine | 107 | 33 |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 106 | 34 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 105 | 58 |
| Enalapril Maleate | Enalapril Maleate | 103 | 28 |
| Telmisartan | Telmisartan | 100 | 20 |
| Naproxen | Naproxen | 96 | 37 |
| Zolpidem Tartrate | Zolpidem Tartrate | 96 | 11 |
| Synthroid | Levothyroxine Sodium | 87 | 16 |
| Atenolol | Atenolol | 85 | 27 |
| Baclofen | Baclofen | 84 | 34 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 82 | 68 |
| Escitalopram Oxalate | Escitalopram Oxalate | 78 | 37 |
| Allopurinol | Allopurinol | 77 | 21 |
| Azelastine Hcl | Azelastine Hcl | 77 | 32 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 77 | 27 |
| Sertraline Hcl | Sertraline Hcl | 76 | 31 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 75 | 66 |
| Citalopram Hbr | Citalopram Hydrobromide | 74 | 24 |
| Memantine Hcl | Memantine Hcl | 74 | 30 |
| Ondansetron Hcl | Ondansetron Hcl | 73 | 39 |
| Cilostazol | Cilostazol | 72 | 30 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 71 | 14 |
| Metformin Hcl Er | Metformin Hcl | 71 | 21 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 68 | 18 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 68 | 18 |
| Glimepiride | Glimepiride | 66 | 13 |
| Nyamyc | Nystatin | 65 | 23 |
| Loperamide | Loperamide Hcl | 63 | 38 |
| Levetiracetam | Levetiracetam | 62 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 61 | 19 |
| Pregabalin | Pregabalin | 61 | 17 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 56 | 49 |
| Silver Sulfadiazine | Silver Sulfadiazine | 55 | 31 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 53 | 16 |
| Fluoxetine Hcl | Fluoxetine Hcl | 53 | 23 |
| Finasteride | Finasteride | 52 | 22 |
| Chlordiazepoxide Hcl | Chlordiazepoxide Hcl | 51 | 18 |
| Lovastatin | Lovastatin | 51 | 12 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 51 | 18 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 50 | 33 |
| Ciclopirox | Ciclopirox | 49 | 17 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 47 | 31 |
| Nystatin | Nystatin | 47 | 28 |
| Duloxetine Hcl | Duloxetine Hcl | 46 | 17 |
| Lansoprazole | Lansoprazole | 46 | 12 |
| Dapagliflozin | Dapagliflozin Propanediol | 45 | 16 |
| Pradaxa | Dabigatran Etexilate Mesylate | 44 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 43 | 14 |
| Methenamine Hippurate | Methenamine Hippurate | 43 | suppressed |
| Lamotrigine | Lamotrigine | 42 | suppressed |
| Risperidone | Risperidone | 42 | 18 |
| Dutasteride | Dutasteride | 41 | 14 |
| Nitroglycerin | Nitroglycerin | 41 | 23 |
| Potassium Chloride | Potassium Chloride | 41 | 16 |
| Oxazepam | Oxazepam | 40 | suppressed |
| Acyclovir | Acyclovir | 39 | 19 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 39 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 39 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 39 | 12 |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 39 | suppressed |
| Ezetimibe | Ezetimibe | 38 | 17 |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 37 | 37 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 37 | suppressed |
| Levoxyl | Levothyroxine Sodium | 36 | suppressed |
| Comfort Ez Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 35 | suppressed |
| Metronidazole | Metronidazole | 35 | 27 |
| Mometasone Furoate | Mometasone Furoate | 35 | 21 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 34 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 33 | suppressed |
| Methylprednisolone | Methylprednisolone | 33 | 24 |
| Amiodarone Hcl | Amiodarone Hcl | 32 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 32 | 18 |
| Entresto | Sacubitril/Valsartan | 32 | suppressed |
| Latanoprost | Latanoprost | 32 | suppressed |
| Prednisone | Prednisone | 32 | 15 |
| Fluocinonide | Fluocinonide | 31 | suppressed |
| Anastrozole | Anastrozole | 30 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 29 | 18 |
| Fluconazole | Fluconazole | 28 | 14 |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 28 | 14 |
| Clobetasol Propionate | Clobetasol Propionate | 27 | 12 |
| Metoclopramide Hcl | Metoclopramide Hcl | 27 | 13 |
| Levofloxacin | Levofloxacin | 25 | 19 |
| Colchicine | Colchicine | 24 | suppressed |
| Estradiol | Estradiol | 24 | 16 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 24 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 23 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 23 | suppressed |
| Myrbetriq | Mirabegron | 23 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 22 | suppressed |
| Cyclosporine | Cyclosporine | 22 | suppressed |
| Erythromycin | Erythromycin Base | 22 | 15 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 22 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 22 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 22 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 22 | suppressed |
| Ofloxacin | Ofloxacin | 21 | 15 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 20 | 15 |
| Gentamicin Sulfate | Gentamicin Sulfate | 20 | suppressed |
| Lidocaine | Lidocaine | 20 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 20 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 18 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 18 | suppressed |
| Testosterone | Testosterone | 18 | suppressed |
| Tradjenta | Linagliptin | 18 | suppressed |
| Bumetanide | Bumetanide | 17 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 17 | suppressed |
| Creon | Lipase/Protease/Amylase | 17 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 17 | suppressed |
| Neomycin-Polymyxin-Hc | Neomycin/Polymyxin B/Hydrocort | 17 | 13 |
| Pravastatin Sodium | Pravastatin Sodium | 17 | suppressed |
| Primidone | Primidone | 17 | suppressed |
| Trulicity | Dulaglutide | 17 | suppressed |
| Amoxicillin | Amoxicillin | 16 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 16 | suppressed |
| Spironolactone | Spironolactone | 16 | suppressed |
| Sucralfate | Sucralfate | 16 | suppressed |
| Verapamil Er | Verapamil Hcl | 16 | suppressed |
| Jardiance | Empagliflozin | 15 | suppressed |
| Prevalite | Cholestyramine | 15 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 14 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 14 | suppressed |
| Topiramate | Topiramate | 14 | suppressed |
| Bicalutamide | Bicalutamide | 13 | suppressed |
| Bupropion Xl | Bupropion Hcl | 13 | suppressed |
| Clindamycin Phosphate | Clindamycin Phosphate | 13 | suppressed |
| Diazepam | Diazepam | 13 | suppressed |
| Insulin Glargine Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Linzess | Linaclotide | 13 | suppressed |
| Ozempic | Semaglutide | 13 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 13 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 13 | suppressed |
| Acetic Acid | Acetic Acid | 12 | 12 |
| Azathioprine | Azathioprine | 12 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 12 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 12 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 12 | suppressed |
| Insulin Aspart Prot Mix 70-30 | Insulin Aspart Prot/Insuln Asp | 12 | suppressed |
| Insulin Lispro | Insulin Lispro | 12 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 12 | suppressed |
| Tegretol Xr | Carbamazepine | 12 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 12 | suppressed |
| Timolol Maleate | Timolol Maleate | 12 | suppressed |
| Trijardy Xr | Empaglifloz/Linaglip/Metformin | 12 | suppressed |
| Trospium Chloride | Trospium Chloride | 12 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 12 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 11 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 11 | suppressed |
| Calcitriol | Calcitriol | 11 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 11 | suppressed |
| Dexilant | Dexlansoprazole | 11 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 11 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 11 | suppressed |
| Valsartan | Valsartan | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $18.22 · 1 records | ABBVIE INC. | BOTOX | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error